New technologies delivered to your inbox Subscribe
The MIT Technology Licenses Office welcomes companies to get to know us personally. We find it most effective to work individually with a company to identify specific areas of interest. We then bring inventions, which specifically match the company's interests to the attention of the company. With 500 new invention disclosures coming into our office each year, our portfolio is constantly changing. The technologies highlighted here do not encompass our entire portfolio. We therefore encourage companies to keep in touch on a regular basis and also to contact us when a particular technology need arises.
Our technology is usually early stage and often requires substantial development by the licensing company before a commercial product is ready for market. Because of this, we often find that the best contact person from the company is one who is knowledgeable about the company's science and technology and also familiar with the long-term strategic plans of the company.
17533 – Non-invasive monitoring of white blood cell (WBC) counts for immune system monitoring In current practice, WBC counts require visits to healthcare centers, blood draws, and lab work involving specialized devices, technicians, reagents and potential biohazards. This invention presents a non-invasive technique with a low-cost, portable, semi-automatic optical equipment to get WBC... Read More
10494-12297 – Biologics can’t be taken orally and are often administered via long hours of intravenous (IV) infusions in a dilute form or via painful hypodermic injections in a viscous, concentrated form. Because of these delivery challenges, patients often fall out of compliance with their treatment regime. Pen injectors and patch pumps for self-administering biologics have been invented... Read More
17559 – Ultrasound transmission agent Typically liquid gel is used in ultrasound procedures to improve the transmission of the ultrasound signals from the transducer to the body. However, conventional liquid hydrogels dry quickly or drip off the patient’s skin quickly. This new compliant and tough hydrogel conforms to the contours of the human body and remains effective for at least 30... Read More
15248 – Methods to reduce excessive negative effects of stress on stress-sensitive mental illnesses. This invention could be of great interest to pharmaceutical companies that have developed strategies for reducing the actions of ghrelin, which are typically used to treat obesity, diabetes, and diseases involving overeating, by providing a new application venue. Currently there are no... Read More
17701 – Methods to reduce the development of stress-sensitive mental illnesses. This invention could be of great interest to pharmaceutical companies that have developed ghrelin or ghrelin receptor agonists, which are typically used to treat other disease conditions such as cachexia and muscle loss, by providing a new application avenue. Currently there are no pharmaceuticals that can... Read More
15865 – Methods for treating stress sensitive conditions. This invention could be of great interest to pharmaceutical companies that have developed growth hormone agonists and antagonists. Currently there are no pharmaceuticals that can be used to prevent the exacerbation or development of stress-sensitive mental illnesses. Consequently, these conditions are treated with the same... Read More
18022 – This technology can be used in capturing optical images of body cavities, organs, as well as stimulate biological tissues. Optical imaging of body cavities and optical stimulation of biological tissues are often considered as two separate procedures. The endoscopy-based optical imaging requires endoscopes that are relatively large in size with a limited structural flexibility and a... Read More
17268 – The synthesis of N-heterocyclic carbene-bis(aryl) carbodiimide (NHC-CDI) is a fundamental discovery, for which specific applications are currently being explored. NHC-CDIs are a novel structural class of molecule with potential application as ligands for Lewis acidic species (e.g., transition metal cations). The development of novel ligand classes is critical to the discovery of... Read More
18005 – This technology can be used in making passive hearing protection device for personnel working in high-noise operational environments such as High intensity noise exposure can severely damage hearing. Conventional earplugs attenuate all sound irrespective of frequency reducing operational capability of the person concerned. On the contrary, state-of-the-art active noise canceling... Read More
16765 – Biofouling refers to the undesirable attachment of organic matters, biomolecules and microbes on submerged surfaces, which diminishes the device performance. The inventors have developed a Zwitterionic polymer coating which, when applied to commercial reverse osmosis (RO) membranes, will provide excellent means to combat biofouling of these surfaces. The invented Zwitterionic... Read More